about
Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center[Use of molecular typing tools for the study of hospital outbreaks of candidemia].Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to MicafunginComparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates.Micafungin is more active against Candida albicans biofilms with high metabolic activity.Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients.The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates.Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points.Erratum for Marcos-Zambrano et al., Antifungal Resistance to Fluconazole and Echinocandins Is Not Emerging in Yeast Isolates Causing Fungemia in a Spanish Tertiary Care Center.Is biofilm production a predictor of catheter-related candidemia?Is catheter-related candidemia a polyclonal infection?Does identification to species level provide sufficient evidence to confirm catheter-related fungemia caused by Candida albicans?Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata.Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.Is Biofilm Production a Prognostic Marker in Adults with Candidemia?[Erratum to "Use of molecular typing tools for the study of hospital outbreaks of candidemia"].Multicentre Determination of Rezafungin (CD101) Susceptibility of Candida species by the EUCAST Method.Does the composition of polystyrene trays affect Candida spp. biofilm formation?Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effectResistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture SamplesPersistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship eraCandida isolates causing candidemia show different degrees of virulence in Galleria mellonella
P50
Q34058322-4290FFD1-4A64-42CB-AAD5-00C3C970934CQ34781161-738991F8-A476-4D68-80A3-1C53AA9D6727Q36933366-E36F91D5-45E5-4B2F-8D19-D8CB69B6B690Q37023317-E6B4D437-F47D-48C3-93E8-C93DDE5EF8FAQ37263358-CF2FED2D-67B3-40B8-824D-535155540BFDQ38869418-85ADE048-77C0-47EB-81E9-201142B43FAAQ39173771-D027E385-B8E0-44CA-9D18-34A073CE0B65Q39230127-71BF0551-8C14-4042-81A7-5162594DD5D6Q40171946-24A32557-E851-4B43-9155-121893FAD469Q40220987-9372064E-8738-46AE-9A3C-285DA5C2B088Q40239343-22305497-C4E8-4D1E-A688-44E810185EDEQ40340923-89EA4DA7-7223-42F1-9677-17ED96942B41Q40441738-FA2B93DF-753E-437C-A58D-73609051C4BCQ40687144-33AC43B9-C54E-4FA0-975D-7EB4303F764BQ40842732-6D066AF5-69B8-4865-B84A-A90E7B4F1FDBQ40920367-6C45BA6B-1732-4045-A7A6-A3FD974E726DQ41738290-28485E5E-CBE4-499F-A621-2BC6E4742BCDQ41987055-ED8B5916-A281-430A-A941-FA79F2550ECFQ42217263-B7BBFFFD-6AE0-4866-8C76-BD736D35F64AQ42224230-AC195AA8-7B36-457F-890E-2B72F8D9FCF0Q42256837-305C7BA3-B1A1-4EDA-BE09-AA55B6A7498EQ49936044-FF1BD838-BA78-4EB3-A465-C417FDBAA59EQ50134184-06B2B09A-F7A8-4E8A-B643-8538DC8E1625Q50165163-71E40068-FDF7-4F4B-8537-08AA7CFC45F5Q50228630-29AEC4AE-DD45-44BA-A210-CFD2B339CF3EQ51149350-F2F7FCC6-2E4C-4B5E-B155-344088985565Q60860304-55EF46F4-7BBA-450F-B307-2281CE4B1348Q60860340-45EBDE89-C453-45CA-B1FD-F3F40565E694Q60860358-CB31E9D1-4850-42F8-BBDA-988048EB5DBFQ91214777-2AE4A26E-0B9D-4B60-8BDF-AE7D015131BEQ92385262-F52468B5-E894-4D3D-81F0-D75D7C02A197
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Judith Marcos-Zambrano
@ast
Laura Judith Marcos-Zambrano
@en
Laura Judith Marcos-Zambrano
@es
Laura Judith Marcos-Zambrano
@nl
type
label
Laura Judith Marcos-Zambrano
@ast
Laura Judith Marcos-Zambrano
@en
Laura Judith Marcos-Zambrano
@es
Laura Judith Marcos-Zambrano
@nl
prefLabel
Laura Judith Marcos-Zambrano
@ast
Laura Judith Marcos-Zambrano
@en
Laura Judith Marcos-Zambrano
@es
Laura Judith Marcos-Zambrano
@nl
P106
P21
P31
P496
0000-0003-1381-6407